help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Plaisancie, P.
Right arrow Articles by Cuber, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Plaisancie, P.
Right arrow Articles by Cuber, J. C.

Endocrinology, Vol 135, 2398-2403, Copyright © 1994 by Endocrine Society


ARTICLES

Regulation of glucagon-like peptide-1-(7-36) amide secretion by intestinal neurotransmitters and hormones in the isolated vascularly perfused rat colon

P Plaisancie, C Bernard, JA Chayvialle and JC Cuber
INSERM U-45, Hopital E. Herriot, Lyon, France.

Glucagon-like peptide-1 (GLP-1) is promptly released from endocrine cells of the distal part of the gut after oral ingestion of a meal. To test the possibility that hormones produced by the proximal small intestine or transmitters of the enteric nervous system may be involved in the early phase of meal-induced GLP-1 secretion, various intestinal regulatory peptides and neurotransmitters of the gut were administered intraarterially in the isolated vascularly perfused rat colon preparation. The release of GLP-1 in the portal effluent was measured by a specific RIA. Intraarterial infusion of glucose-dependent insulinotropic peptide (GIP) over the concentration range 0.25-1 nM evoked a dose-dependent release of GLP-1, with a maximal response of 350% of the basal value. Tetrodotoxin did not modify the GIP-induced release of GLP-1. Secretin or cholecystokinin did not stimulate the secretion of GLP-1. Bombesin (10(-9)-10(-7) M) provoked a dose- dependent release of GLP-1, consisting of an early peak, followed by a sustained response. Calcitonin gene-related peptide (5 x 10(-8) M) induced a dramatic rise of GLP-1 immunoreactivity in the portal effluent (peak at 800% of the basal value 10 min after the start of infusion). Similarly, the beta-adrenergic agonist isoproterenol at concentrations of 10(-7) and 10(-6) M provoked a pronounced release of GLP-1 (peak at 500% of the basal value with 10(-6) M isoproterenol). Finally, the muscarinic cholinergic agonist bethanechol at a concentration of 10(-4) M evoked a gradual increase in GLP-1 immunoreactivity, which reached a maximal value (900% over basal) at the end of the 30-min infusion period. The lowest concentration of bethanechol used in the present study (10(-5) M) did not increase portal GLP-1 immunoreactivity over the basal value. Tetrodotoxin did not modify the bethanechol-, isoproterenol-, calcitonin gene-related peptide-, or bombesin-induced GLP-1 release. In conclusion, the present study conducted with the isolated vascularly perfused rat colon shows that there are interactions between the two most potent incretins, GIP and GLP-1, probably through an enteroendocrine pathway. Additionally, several transmitters of the gut are potent stimulants of GLP-1 release and, therefore, represent potential tools in the treatment of the noninsulin-dependent diabetes mellitus.


This article has been cited by other articles:


Home page
EndocrinologyHome page
Z.-L. Chu, C. Carroll, J. Alfonso, V. Gutierrez, H. He, A. Lucman, M. Pedraza, H. Mondala, H. Gao, D. Bagnol, et al.
A Role for Intestinal Endocrine Cell-Expressed G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Peptide Release
Endocrinology, May 1, 2008; 149(5): 2038 - 2047.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. J. Holst
The Physiology of Glucagon-like Peptide 1
Physiol Rev, October 1, 2007; 87(4): 1409 - 1439.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. E. Lim and P. L. Brubaker
Glucagon-Like Peptide 1 Secretion by the L-Cell: The View From Within
Diabetes, December 1, 2006; 55(Supplement_2): S70 - S77.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
X. Qin, H. Shen, M. Liu, Q. Yang, S. Zheng, M. Sabo, D. A. D'Alessio, and P. Tso
GLP-1 reduces intestinal lymph flow, triglyceride absorption, and apolipoprotein production in rats
Am J Physiol Gastrointest Liver Physiol, May 1, 2005; 288(5): G943 - G949.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. Hansen, S. Lampert, H. Mineo, and J. J. Holst
Neural regulation of glucagon-like peptide-1 secretion in pigs
Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E939 - E947.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Anini, T. Hansotia, and P. L. Brubaker
Muscarinic Receptors Control Postprandial Release of Glucagon-Like Peptide-1: In Vivo and in Vitro Studies in Rats
Endocrinology, June 1, 2002; 143(6): 2420 - 2426.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
G. Cuche, J. C. Cuber, and C. H. Malbert
Ileal short-chain fatty acids inhibit gastric motility by a humoral pathway
Am J Physiol Gastrointest Liver Physiol, November 1, 2000; 279(5): G925 - G930.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Moro, F. Levenez, E. Nemoz-Gaillard, S. Pellissier, P. Plaisancie, and J. C. Cuber
Release of Guanylin Immunoreactivity from the Isolated Vascularly Perfused Rat Colon
Endocrinology, July 1, 2000; 141(7): 2594 - 2599.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. Hansen, B. Hartmann, T. Bisgaard, H. Mineo, P. N. Jorgensen, and J. J. Holst
Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum
Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E1010 - E1018.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
A Barcelo, J Claustre, F Moro, J-A Chayvialle, J-C Cuber, and P Plaisancie
Mucin secretion is modulated by luminal factors in the isolated vascularly perfused rat colon
Gut, February 1, 2000; 46(2): 218 - 224.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
T. J. Kieffer and J. Francis Habener
The Glucagon-Like Peptides
Endocr. Rev., December 1, 1999; 20(6): 876 - 913.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
P. Plaisancie, A. Barcelo, F. Moro, J. Claustre, J.-A. Chayvialle, and J.-C. Cuber
Effects of neurotransmitters, gut hormones, and inflammatory mediators on mucus discharge in rat colon
Am J Physiol Gastrointest Liver Physiol, November 1, 1998; 275(5): G1073 - G1084.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
V. Dumoulin, F. Moro, A. Barcelo, T. Dakka, and J.-C. Cuber
Peptide YY, Glucagon-Like Peptide-1, and Neurotensin Responses to Luminal Factors in the Isolated Vascularly Perfused Rat Ileum
Endocrinology, September 1, 1998; 139(9): 3780 - 3786.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. B. Damholt, A. M. J. Buchan, and H. Kofod
Glucagon-Like-Peptide-1 Secretion from Canine L-Cells Is Increased by Glucose-Dependent-Insulinotropic Peptide but Unaffected by Glucose
Endocrinology, April 1, 1998; 139(4): 2085 - 2091.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society